NewEdge Advisors LLC Buys 1,458 Shares of Humana Inc. $HUM

NewEdge Advisors LLC grew its stake in shares of Humana Inc. (NYSE:HUM) by 85.0% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,174 shares of the insurance provider’s stock after purchasing an additional 1,458 shares during the quarter. NewEdge Advisors LLC’s holdings in Humana were worth $550,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in HUM. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Humana by 4.1% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock valued at $66,207,000 after acquiring an additional 9,960 shares during the period. Sustainable Insight Capital Management LLC raised its stake in shares of Humana by 23.7% during the fourth quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock valued at $6,341,000 after acquiring an additional 4,740 shares during the last quarter. Swedbank AB boosted its holdings in shares of Humana by 6.2% during the fourth quarter. Swedbank AB now owns 111,803 shares of the insurance provider’s stock worth $28,636,000 after purchasing an additional 6,534 shares during the period. North Dakota State Investment Board purchased a new stake in shares of Humana during the fourth quarter worth about $1,517,000. Finally, Pzena Investment Management LLC grew its stake in shares of Humana by 1.0% in the fourth quarter. Pzena Investment Management LLC now owns 4,072,208 shares of the insurance provider’s stock worth $1,043,015,000 after purchasing an additional 41,125 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Price Performance

Shares of NYSE HUM opened at $379.22 on Friday. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $428.88. The stock has a market capitalization of $45.54 billion, a P/E ratio of 35.88, a P/E/G ratio of 2.18 and a beta of 0.72. The company’s 50-day moving average is $383.38 and its 200 day moving average is $281.59. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business had revenue of $40.89 billion during the quarter, compared to analyst estimates of $40.58 billion. During the same period last year, the business posted $6.27 earnings per share. Humana’s quarterly revenue was up 26.2% compared to the same quarter last year. On average, sell-side analysts expect that Humana Inc. will post 9.08 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on HUM shares. Deutsche Bank Aktiengesellschaft initiated coverage on Humana in a report on Thursday, July 30th. They set a “hold” rating on the stock. TD Cowen increased their price objective on Humana from $350.00 to $370.00 and gave the stock a “hold” rating in a report on Friday, July 31st. Evercore upgraded Humana from an “in-line” rating to an “outperform” rating and set a $480.00 price objective on the stock in a research report on Wednesday, July 29th. Piper Sandler raised Humana from a “hold” rating to an “overweight” rating and set a $463.00 target price on the stock in a research note on Thursday, July 30th. Finally, Barclays upped their target price on Humana from $344.00 to $407.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Fourteen analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $395.22.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.